
OrthoPediatrics (KIDS) Stock Forecast & Price Target
OrthoPediatrics (KIDS) Analyst Ratings
Bulls say
OrthoPediatrics is benefiting from a powerful new-product super cycle and continued share gains in an underpenetrated pediatric orthopedics market, as 3Q26 revenue rose 18.6% to $72.7 million and beat expectations by about 6% while Trauma & Deformity and Scoliosis both posted strong growth. Management’s raised FY26 sales guide of $270 million to $273 million, alongside reaffirmed adjusted EBITDA of $25 million and expected free cash flow breakeven for 2026, suggests operating leverage is building even as launch investments and compensation timing temporarily weighed on EBITDA. With higher-ASP products like 3P Hip and VerteGlide starting to contribute, broader commercial availability expected to expand, and positive free cash flow from 2027 onwards, the company appears positioned for sustained top-line growth and improving profitability.
Bears say
OrthoPediatrics is viewed negatively because its growth depends on successfully converting current and new products into revenue, yet there is a meaningful risk that share gains will be smaller than expected and that margin expansion will fall short. Competition from both large established healthcare companies and smaller entrants with differentiated technology could limit market share gains and create pricing pressure, while the concentrated end market heightens vulnerability to quarterly volatility from disruptions or procedural slowdowns at key accounts. In addition, acquisition and integration risk from continued M&A and liquidity risk add financial uncertainty, making the company’s execution profile fragile.
This aggregate rating is based on analysts' research of OrthoPediatrics and is not a guaranteed prediction by Public.com or investment advice.
OrthoPediatrics (KIDS) Analyst Forecast & Price Prediction
Start investing in OrthoPediatrics (KIDS)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About OrthoPediatrics (KIDS) Forecast
OrthoPediatrics (KIDS) Analyst Forecast & Price Prediction
Start investing in OrthoPediatrics (KIDS)
Order type
Buy in
Order amount
Est. shares
0 shares